(2S,3S)-2-Amino-3-methylpentanoic acid
Brand names,
(2S,3S)-2-Amino-3-methylpentanoic acid
Analogs
- (2S,3S)-2-Amino-3-methylpentanoic acid
- (2S,3S)-a-Amino-b-methyl-n-valeric acid
- (2S,3S)-a-Amino-b-methylvaleric acid
- (S)-Isoleucine
- (S,S)-Isoleucine
- 2-Amino-3-methylvaleric acid
- 2S,3S-Isoleucine
- Isoleucine
- Isoleucine, L-
- L-(+)-Isoleucine
- L-Ile
- L-Isoleucine
- L-Isoleucine (JP14/USP)
- L-Norvaline, 3-methyl-, erythro-
- Pentanoic acid, 2-amino-3-methyl-, (2S,3S)-
- [S-(R*,R*)]-2-Amino-3-methylpentanoic acid
- erythro-L-Isoleucine
(2S,3S)-2-Amino-3-methylpentanoic acid
Brand Names Mixture
(2S,3S)-2-Amino-3-methylpentanoic acid
Chemical_Formula
C6H13N1O2
(2S,3S)-2-Amino-3-methylpentanoic acid
RX_link
No information avaliable
(2S,3S)-2-Amino-3-methylpentanoic acid
fda sheet
(2S,3S)-2-Amino-3-methylpentanoic acid
msds (material safety sheet)
(2S,3S)-2-Amino-3-methylpentanoic acid
Synthesis Reference
No information avaliable
(2S,3S)-2-Amino-3-methylpentanoic acid
Molecular Weight
131.174 g/mol
(2S,3S)-2-Amino-3-methylpentanoic acid
Melting Point
168-170 oC
(2S,3S)-2-Amino-3-methylpentanoic acid
H2O Solubility
No information avaliable
(2S,3S)-2-Amino-3-methylpentanoic acid
State
Solid
(2S,3S)-2-Amino-3-methylpentanoic acid
LogP
-1.743
(2S,3S)-2-Amino-3-methylpentanoic acid
Dosage Forms
Capsules, powder, tablets
(2S,3S)-2-Amino-3-methylpentanoic acid
Indication
The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.
(2S,3S)-2-Amino-3-methylpentanoic acid
Pharmacology
They provide ingredients for the manufacturing of other essential biochemical components in the body, some of which are utilized for the production of energy, stimulants to the upper brain and helping you to be more alert.
(2S,3S)-2-Amino-3-methylpentanoic acid
Absorption
Absorbed from the small intestine by a sodium-dependent active-transport process
(2S,3S)-2-Amino-3-methylpentanoic acid
side effects and Toxicity
Symptoms of hypoglycemia, increased mortality in ALS patients taking large doses of BCAAs
(2S,3S)-2-Amino-3-methylpentanoic acid
Patient Information
No information avaliable
(2S,3S)-2-Amino-3-methylpentanoic acid
Organisms Affected
Humans and other mammals